Shortly after Plk1 was described in mammals, growing shreds of evidence showed that Plk1 is commonly upregulated in a wide variety of tumors, and its overexpression has been validated as a prognostic marker in a subset of these cancers [12,13,14,15,16,17]. Here, PLK1 is linked to cancer.